Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Daprodustat

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,967Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Silodosin,Elagolix sodium,Daprodustat Gained WC certificate
    Silodosin,Elagolix sodium,Daprodustat Gained WC certificate

    04 Jun 2024

    // PRESS RELEASE

    https://www.loncompharm.com/Silodosin-Elagolix-sodium-Daprodustat-and-Vonprazon-Fumarate-Gained-WC-certificate-id48765776.html

    PRESS RELEASE
    04 Jun 2024
    Share Share
    Silodosin,Elagolix sodium,Daprodustat & Vonprazon Fumarate Gained WC certificate
    Silodosin,Elagolix sodium,Daprodustat & Vonprazon Fumarate Gained WC certificate

    04 Jun 2024

    // PRESS RELEASE

    https://www.loncompharm.com/Silodosin-Elagolix-sodium-Daprodustat-and-Vonprazon-Fumarate-Gained-WC-certificate-id48765776.html

    PRESS RELEASE
    04 Jun 2024
    Share Share
    Revarazan Hcl For Acute Gastritis, Chronic Gastritis Gastric Mucosal Lesions
    Revarazan Hcl For Acute Gastritis, Chronic Gastritis Gastric Mucosal Lesions

    28 Mar 2024

    // PRESS RELEASE

    https://www.tantuchemicals.com/news/revarazan-hcl-for-acute-gastritis-chronic-gas-76202020.html

    PRESS RELEASE
    28 Mar 2024
    Share Share
    GSK scraps plan to launch oral anemia drug beyond US, Japan
    GSK scraps plan to launch oral anemia drug beyond US, Japan

    27 Jul 2023

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/pharma/gsk-scraps-plan-launch-oral-anemia-drug-eu-ceases-further-expansion

    Angus Liu FIERCE PHARMA
    27 Jul 2023
    Share Share
    Ami Lifescices announce that USDMF for Daprodustat API has been filed US FDA.
    Ami Lifescices announce that USDMF for Daprodustat API has been filed US FDA.

    30 Jun 2023

    // PRESS RELEASE

    https://amilifesciences.com/media.php

    PRESS RELEASE
    30 Jun 2023
    Share Share
    GSK receives positive CHMP opinion recommending authorisation of daprodustat
    GSK receives positive CHMP opinion recommending authorisation of daprodustat

    26 Jun 2023

    // PRESS RELEASE

    https://www.gsk.com/en-gb/media/press-releases/gsk-receives-positive-chmp-opinion/

    PRESS RELEASE
    26 Jun 2023
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.